United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/05/26
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-TermZacks Investment Research • 12/10/25
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare BaseInvestors Business Daily • 11/21/25
United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/18/25
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-TermZacks Investment Research • 11/12/25
United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal DiseaseBusiness Wire • 11/03/25
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss MarkZacks Investment Research • 10/29/25
Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/29/25
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial ResultsBusiness Wire • 10/29/25
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/22/25
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025Business Wire • 10/15/25
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual MeetingBusiness Wire • 10/13/25